Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,147,854
+$250,397 QoQ
Shares Held
957
-5.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#3,008
of 4,605 holders
Holding Since
Sep 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Diametric Capital, LP holds $1,566,039 across 2 Drug Manufacturers - General names. LLY ranks #1 (73.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
957 | $1,147,854 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
3,310 | $418,185 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,147,854 | 957 | Shares | Defined | 2026-08-14 | |
| 2024-09-30 | $897,457 | 1,013 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,507,457 | 1,665 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $929,662 | 1,195 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $485,572 | 833 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $712,771 | 1,327 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $557,148 | 1,188 | Shares | Defined | 2023-08-11 | |
| 2022-09-30 | $1,038,923 | 3,213 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||